| BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives |
Globe Newswire |
06/22 |
07:30 |
| FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations |
Globe Newswire |
06/22 |
07:30 |
| SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026 |
Globe Newswire |
06/22 |
07:30 |
| Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 |
Globe Newswire |
06/22 |
07:30 |
| Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY |
Globe Newswire |
06/22 |
07:30 |
| New 'Your Year' Planners Team Up with Zebra Pen Ahead of the Back-to-School Season |
Globe Newswire |
06/22 |
07:30 |
| AP Decision Notes: What to expect in Maryland’s state primary |
AP Online |
06/22 |
07:19 |
| CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies |
Globe Newswire |
06/22 |
07:04 |
| Brunswick Corporation Announces Operational Updates at Lowell Facility |
Globe Newswire |
06/22 |
07:00 |
| Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031 |
Globe Newswire |
06/22 |
07:00 |
| TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation |
Globe Newswire |
06/22 |
07:00 |
| Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund Grants |
Globe Newswire |
06/22 |
07:00 |
| Robinhood Announces Private Offering of $2.0 Billion of Convertible Senior Notes Due 2029 |
Globe Newswire |
06/22 |
07:00 |
| Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) |
Globe Newswire |
06/22 |
07:00 |
| Auddia Announces LT350 Advancement Toward First AI Datacenter Deployment, Engaging Fresh Consulting to Lead Engineering and Development |
Globe Newswire |
06/22 |
07:00 |
| Digital Realty Announces Transactions to Drive Continued Platform Growth |
Globe Newswire |
06/22 |
07:00 |
| Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program |
Globe Newswire |
06/22 |
07:00 |
| Fervo Energy Reports First Quarter 2026 Results |
Globe Newswire |
06/22 |
07:00 |
| QTREX Announces Management Share Purchase Plan |
Globe Newswire |
06/22 |
07:00 |
| Gumption Expands California and Larger West Coast Presence with Addition of Commercial Real Estate Finance Veteran John Brooks |
Globe Newswire |
06/22 |
07:00 |
| G2 Goldfields Receives Court Approval for Arrangement With G Mining and Spin-Out of G3 Goldfields |
Globe Newswire |
06/22 |
07:00 |
| Lithium Argentina Reports 2026 Annual General Meeting Results |
Globe Newswire |
06/22 |
07:00 |
| Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson |
Globe Newswire |
06/22 |
07:00 |
| Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus |
Globe Newswire |
06/22 |
07:00 |
| NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression |
Globe Newswire |
06/22 |
07:00 |
